Literature DB >> 17119058

The human leukocyte antigen class I region is associated with EBV-positive Hodgkin's lymphoma: HLA-A and HLA complex group 9 are putative candidate genes.

Marijke Niens1, Anke van den Berg, Arjan Diepstra, Ilja M Nolte, Gerrit van der Steege, Alice Gallagher, G Malcolm Taylor, Ruth F Jarrett, Sibrand Poppema, Gerard J te Meerman.   

Abstract

Various studies have indicated that the human leukocyte antigen (HLA) region is associated with Hodgkin's lymphoma. We recently showed a specific association of the HLA class I region with EBV-positive Hodgkin's lymphoma cases. One haplotype of two consecutive microsatellite markers (D6S265 and D6S510) was overrepresented in the patient group, whereas another haplotype was underrepresented. Here, we did fine mapping of this region of approximately 400 kb as a next step to find the causative single-nucleotide polymorphism(s) (SNP). To select candidate SNPs for screening the total study population, several known SNPs were determined by sequencing two individuals homozygous for either of the above-mentioned associated haplotypes. Seven SNPs displayed different alleles in these two individuals and were therefore analyzed in the total study population, including 238 Hodgkin's lymphoma patients and 365 family-based controls. All seven SNPs showed significant association with the EBV-positive patient group. Two of these SNPs were analyzed in a Scottish Hodgkin's lymphoma population and revealed significant associations as well. The associated SNPs are located nearby two putative candidate genes: HLA-A and HLA complex group 9. HLA-A represents the most interesting target because of its consistent expression in EBV-positive Hodgkin's lymphoma cases and its ability to present EBV-derived peptides to cytotoxic T cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17119058     DOI: 10.1158/1055-9965.EPI-06-0476

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  18 in total

1.  Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3.

Authors:  Ka-Po Tse; Wen-Hui Su; Kai-Ping Chang; Ngan-Ming Tsang; Chia-Jung Yu; Petrus Tang; Lee-Chu See; Chuen Hsueh; Min-Lee Yang; Sheng-Po Hao; Hong-Yi Li; Ming-Hsi Wang; Li-Ping Liao; Lih-Chyang Chen; Sheue-Rong Lin; Timothy J Jorgensen; Yu-Sun Chang; Yin Yao Shugart
Journal:  Am J Hum Genet       Date:  2009-08-06       Impact factor: 11.025

2.  HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma.

Authors:  Henrik Hjalgrim; Klaus Rostgaard; Paul C D Johnson; Annette Lake; Lesley Shield; Ann-Margaret Little; Karin Ekstrom-Smedby; Hans-Olov Adami; Bengt Glimelius; Stephen Hamilton-Dutoit; Eleanor Kane; G Malcolm Taylor; Alex McConnachie; Lars P Ryder; Christer Sundstrom; Paal Skytt Andersen; Ellen T Chang; Freda E Alexander; Mads Melbye; Ruth F Jarrett
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-22       Impact factor: 11.205

3.  Generation of multi-leukemia antigen-specific T cells to enhance the graft-versus-leukemia effect after allogeneic stem cell transplant.

Authors:  G Weber; U Gerdemann; I Caruana; B Savoldo; N F Hensel; K R Rabin; E J Shpall; J J Melenhorst; A M Leen; A J Barrett; C M Bollard
Journal:  Leukemia       Date:  2013-03-01       Impact factor: 11.528

4.  Whole exome sequencing in families at high risk for Hodgkin lymphoma: identification of a predisposing mutation in the KDR gene.

Authors:  Melissa Rotunno; Mary L McMaster; Joseph Boland; Sara Bass; Xijun Zhang; Laurie Burdett; Belynda Hicks; Sarangan Ravichandran; Brian T Luke; Meredith Yeager; Laura Fontaine; Paula L Hyland; Alisa M Goldstein; Stephen J Chanock; Neil E Caporaso; Margaret A Tucker; Lynn R Goldin
Journal:  Haematologica       Date:  2016-06-13       Impact factor: 9.941

5.  HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection.

Authors:  Karen A McAulay; Craig D Higgins; Karen F Macsween; Annette Lake; Ruth F Jarrett; Faye L Robertson; Hilary Williams; Dorothy H Crawford
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

6.  Racial/ethnic variation in EBV-positive classical Hodgkin lymphoma in California populations.

Authors:  Sally L Glaser; Margaret L Gulley; Christina A Clarke; Theresa H Keegan; Ellen T Chang; Sarah J Shema; Fiona E Craig; Joseph A Digiuseppe; Ronald F Dorfman; Risa B Mann; Hoda Anton-Culver; Richard F Ambinder
Journal:  Int J Cancer       Date:  2008-10-01       Impact factor: 7.396

7.  HLA associations in classical Hodgkin lymphoma: EBV status matters.

Authors:  Xin Huang; Kushi Kushekhar; Ilja Nolte; Wierd Kooistra; Lydia Visser; Ilby Bouwman; Niels Kouprie; Rianne Veenstra; Gustaaf van Imhoff; Bianca Olver; Richard S Houlston; Sibrand Poppema; Arjan Diepstra; Bouke Hepkema; Anke van den Berg
Journal:  PLoS One       Date:  2012-07-10       Impact factor: 3.240

8.  Further evidence for the existence of major susceptibility of nasopharyngeal carcinoma in the region near HLA-A locus in Southern Chinese.

Authors:  Manli Zhao; Hongbing Cai; Xin Li; Hang Zheng; Xuexi Yang; Weiyi Fang; Longcheng Zhang; Ganguan Wei; Ming Li; Kaitai Yao; Xin Li
Journal:  J Transl Med       Date:  2012-03-22       Impact factor: 5.531

9.  Evaluation and integration of genetic signature for prediction risk of nasopharyngeal carcinoma in Southern China.

Authors:  Xiuchan Guo; Cheryl A Winkler; Ji Li; Li Guan; Minzhong Tang; Jian Liao; Hong Deng; Guy de Thé; Yi Zeng; Stephen J O'Brien
Journal:  Biomed Res Int       Date:  2014-08-10       Impact factor: 3.411

10.  The association of HLA-class I and class II with Hodgkin's lymphoma in Iranian patients.

Authors:  Arezou Sayad; Mohammad Taghi Akbari; Mahshid Mehdizadeh; Abolfazl Movafagh; Abbas Hajifathali
Journal:  Biomed Res Int       Date:  2014-05-21       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.